• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年抑郁症患病率及治疗进展:综述

Advances in the prevalence and treatment of depression for adolescents: a review.

作者信息

Yin Chunyu, Xu Mengting, Zong Zhiyuan

机构信息

Department of Neonatal Medical Center, Children's Hospital of Nanjing Medical University, Nanjing, China.

School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.

出版信息

Front Pharmacol. 2025 May 6;16:1574574. doi: 10.3389/fphar.2025.1574574. eCollection 2025.

DOI:10.3389/fphar.2025.1574574
PMID:40406494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12096414/
Abstract

BACKGROUND

Depression is a psychological condition in adolescents caused by various factors. Many serious consequences can be associated with depression, such as irritability, emotional instability, and suicide. Meanwhile, the incidence of depression and suicide among adolescents was also affected during the pandemic of COVID-19 in 2019. This phenomenon of adolescent depression should be drawn extensive concern by the community, which affects their physical and mental health.

MAIN BODY

This review describes the epidemiology, high-risk factors, and treatment of adolescent depression. The onset of depression is probably attributable to preterm birth, growth environment, genetic. We also identify that the COVID-19 pandemic, initiated in late 2019,affects adolescent mental health. Antidepressants and psychotherapy are conventional treatments for depressive disorders. However, it is controversial whether antidepressants are as effective and safer as psychotherapy, and a combination of the two could provide more benefit to this population than antidepressants alone. We also summarize some antidepressants developed for novel targets. Improving the efficacy and safety of treatment to reduce the suicide rate among adolescents is the primary goal of clinical research. Existing treatment modalities and drugs are not sufficient to achieve clinical demands, so that new therapeutic targets will be promising for such patients.

CONCLUSION

A variety of factors can contribute to depression in adolescents. Adolescent depression should be mainly treated with non-pharmacological. A combination of guideline-recommended antidepressants should be used if uncontrolled with non-pharmacological, but adverse drug reactions and suicidal ideation should be closely monitored.

摘要

背景

抑郁症是青少年中由多种因素引起的一种心理状况。抑郁症可能会引发许多严重后果,如易怒、情绪不稳定和自杀。同时,2019年新冠疫情大流行期间,青少年抑郁症和自杀的发生率也受到了影响。青少年抑郁症这一现象应引起社会的广泛关注,因为它会影响青少年的身心健康。

主体

本综述描述了青少年抑郁症的流行病学、高危因素及治疗方法。抑郁症的发病可能归因于早产、生长环境、遗传因素。我们还发现,始于2019年末的新冠疫情大流行影响了青少年的心理健康。抗抑郁药和心理治疗是治疗抑郁症的传统方法。然而,抗抑郁药是否与心理治疗一样有效且更安全,以及两者联合使用是否比单独使用抗抑郁药能为这一人群带来更多益处,仍存在争议。我们还总结了一些针对新靶点研发的抗抑郁药。提高治疗的有效性和安全性以降低青少年自杀率是临床研究的主要目标。现有的治疗方式和药物不足以满足临床需求,因此新的治疗靶点对这类患者来说很有前景。

结论

多种因素可导致青少年抑郁症。青少年抑郁症应以非药物治疗为主。如果非药物治疗无法控制病情,则应联合使用指南推荐的抗抑郁药,但应密切监测药物不良反应和自杀意念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097d/12096414/44ce6ac41a26/FPHAR_fphar-2025-1574574_wc_abs.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097d/12096414/44ce6ac41a26/FPHAR_fphar-2025-1574574_wc_abs.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097d/12096414/44ce6ac41a26/FPHAR_fphar-2025-1574574_wc_abs.jpg

相似文献

1
Advances in the prevalence and treatment of depression for adolescents: a review.青少年抑郁症患病率及治疗进展:综述
Front Pharmacol. 2025 May 6;16:1574574. doi: 10.3389/fphar.2025.1574574. eCollection 2025.
2
New generation antidepressants for depression in children and adolescents: a network meta-analysis.新一代抗抑郁药治疗儿童和青少年抑郁症:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2.
3
Controversies in the Pharmacotherapy of Adolescent Depression.青少年抑郁症药物治疗的争议。
Curr Pharm Des. 2022;28(24):1975-1984. doi: 10.2174/1381612828666220526150153.
4
Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis.抗抑郁药、心理干预及其联合治疗儿童和青少年抑郁症的比较疗效和可接受性:网状Meta分析方案
BMJ Open. 2017 Aug 11;7(8):e016608. doi: 10.1136/bmjopen-2017-016608.
5
Psychological therapies for treatment-resistant depression in adults.成人难治性抑郁症的心理治疗
Cochrane Database Syst Rev. 2018 May 14;5(5):CD010558. doi: 10.1002/14651858.CD010558.pub2.
6
Pharmacotherapy of major depressive disorder in adolescents.青少年重性抑郁障碍的药物治疗。
Expert Opin Pharmacother. 2010 Feb;11(3):375-86. doi: 10.1517/14656560903527226.
7
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.心理治疗与抗抑郁药物单独及联合使用治疗儿童和青少年抑郁症
Cochrane Database Syst Rev. 2012 Nov 14;11:CD008324. doi: 10.1002/14651858.CD008324.pub2.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
The impact of the COVID-19 pandemic on children and young people.新冠疫情对儿童和青少年的影响。
Psychiatriki. 2023 Dec 29;34(4):265-268. doi: 10.22365/jpsych.2023.024. Epub 2023 Nov 14.
10
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.心理疗法与抗抑郁药物单独及联合使用治疗儿童和青少年抑郁症的比较。
Cochrane Database Syst Rev. 2014 Nov 30;2014(11):CD008324. doi: 10.1002/14651858.CD008324.pub3.

本文引用的文献

1
The transcription factor MEF2C restrains microglial overactivation by inhibiting kinase CDK2.转录因子MEF2C通过抑制激酶CDK2来抑制小胶质细胞过度激活。
Immunity. 2025 Apr 8;58(4):946-960.e10. doi: 10.1016/j.immuni.2025.02.026. Epub 2025 Mar 25.
2
Psychoneuroendocrine stress response in female and male youth with major depressive disorder.患有重度抑郁症的青年女性和男性的心理神经内分泌应激反应。
J Child Psychol Psychiatry. 2025 Mar 23. doi: 10.1111/jcpp.14168.
3
Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021.
2019年至2021年新冠疫情期间抑郁症全球负担加速上升。
Sci Rep. 2025 Mar 19;15(1):9529. doi: 10.1038/s41598-025-93923-4.
4
Psychiatric and neuropsychiatric sequelae of COVID-19 within 2 years: a multinational cohort study.新冠病毒感染后2年内的精神和神经精神后遗症:一项多国队列研究
BMC Med. 2025 Mar 7;23(1):144. doi: 10.1186/s12916-025-03952-z.
5
Exploring the role of gut microbiota in depression: Pathogenesis and therapeutic insights.探索肠道微生物群在抑郁症中的作用:发病机制与治疗见解。
Asian J Psychiatr. 2025 Mar;105:104411. doi: 10.1016/j.ajp.2025.104411. Epub 2025 Feb 21.
6
The Burden of adolescent depression and the impact of COVID-19 across 204 countries and regions from 1990 to 2021: results from the 2021 global burden of disease study.1990年至2021年期间204个国家和地区青少年抑郁症负担及新冠疫情的影响:2021年全球疾病负担研究结果
Sci Rep. 2025 Feb 15;15(1):5658. doi: 10.1038/s41598-024-84843-w.
7
Gut Microbiome, Diet and Depression: Literature Review of Microbiological, Nutritional and Neuroscientific Aspects.肠道微生物群、饮食与抑郁症:微生物学、营养学和神经科学方面的文献综述
Curr Nutr Rep. 2025 Feb 10;14(1):30. doi: 10.1007/s13668-025-00619-2.
8
Trajectories of Chinese adolescent depression before and after COVID-19: A cross-temporal meta-analysis with segmented regression.新冠疫情前后中国青少年抑郁的轨迹:一项采用分段回归的交叉时间元分析
J Affect Disord. 2025 Mar 15;373:333-344. doi: 10.1016/j.jad.2024.12.094. Epub 2024 Dec 29.
9
The relationship between anxiety and depression in adolescent depression patients: The mediating effect of hope level and coping modes.青少年抑郁症患者焦虑与抑郁的关系:希望水平与应对方式的中介作用
Heliyon. 2024 Jul 31;10(15):e35466. doi: 10.1016/j.heliyon.2024.e35466. eCollection 2024 Aug 15.
10
Psychosocial alterations during the COVID-19 pandemic and the global burden of anxiety and major depressive disorders in adolescents, 1990-2021: challenges in mental health amid socioeconomic disparities.新冠大流行期间的心理社会变化和青少年时期焦虑症和重度抑郁症的全球负担:社会经济差异背景下的心理健康挑战。
World J Pediatr. 2024 Oct;20(10):1003-1016. doi: 10.1007/s12519-024-00837-8. Epub 2024 Aug 20.